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ELLULAR development occurs  in  several  stages  in 
higher eukaryotic organisms. This process is gener- 
ally characterized by the loss of pluripotency and re- 
striction of possible cell fates, leading to a  highly "deter- 
mined" cell that can either proliferate or differentiate into a 
defined end-type cell. The process of cell differentiation can 
be studied in many cell types, some of which offer convenient 
culture systems. We are particularly interested in the devel- 
opment of fat cells. In our studies we have had two objec- 
tives. First, to use adipocyte differentiation as a model for 
the process of signal transduction in cellular development, 
whereby extracellular stimulation leads to the ultimate ex- 
pression of end-product genes, extinction of genes character- 
istic of the precursor cells, and phenotypic differentiation. In 
addition, because the adipose cell is centrally involved in 
certain pathological syndromes of systemic energy balance, 
most notably obesity, obesity-linked diabetes, and cachexia 
(fat and muscle wasting), we are interested in using studies 
of gene control to improve our understanding of these dis- 
orders. 
Because cancer is a disease involving loss of  cellular growth 
control and disruption of the usual pattern of cell differentia- 
tion, there has been much interest in the role of oncogenes 
and their normal cellular counterparts (protooncogenes) in 
controlling patterns of gene expression during differentia- 
tion. Many studies using the expression of oncogenes intro- 
duced into cells have shown profound effects, either promot- 
ing or inhibiting differentiation depending on the oncogene 
and cellular system being analyzed (4, 5, 8,  13,  17,  19, 21, 
24). One difficulty with this approach has been that the con- 
nection between the oncoprotein and the ultimate alterations 
in gene expression is usually not clear. We have recently ap- 
proached  the  same goals through a  different method.  By 
studying in detail the cis- and trans-acting components in- 
volved in activating a particular gene during adipocyte differ- 
entiation, we have identified the first gene product related to 
an oncogene (fos) which appears to play a direct role in con- 
trolling gene expression during differentiation. This will be 
the major subject discussed below. 
Adipose Differentiation in Cultured Cell Lines 
The study of adipocyte development became much simpler 
with the isolation of preadipocyte cell lines that differentiate 
in culture, initially by Green and Kehinde (16) and later by 
many others. These lines typically resemble fibroblasts when 
kept in a growing state but undergo morphological and bio- 
chemical changes characteristic of fat cells when they stop 
growing under appropriate culture conditions. Many or most 
of the key enzymes of fatty acid and triglyceride synthesis 
are greatly increased during this process.  The striking change 
in cell shape during adipocyte differentiation is independent 
of lipid accumulation; blocking triglyceride formation by 
depriving cells of biotin has little or no effect on the altera- 
tions in cell morphology (20).  The gross changes in cell 
morphology are accompanied by alterations in the synthesis 
and  assembly  of cytoskeletal proteins  (28).  Experiments 
which interfered with morphological conversion using exog- 
enous extracellular matrix components suggest that changes 
in cellular structure may be necessary for the programmed 
alterations in gene expression (29).  The differentiation of 
adipocytes is accelerated by a number of  defined or undefined 
factors including FCS, insulin, growth hormone, glucocorti- 
coids,  sex steroids, thyroid hormones, and indomethacin. 
Differentiation is inhibited by interferon, retinoic acid, inter- 
leukin-1,  tumor promoters, and tumor necrosis factor.  It is 
likely that at least some of these factors play a physiological 
role in adipocyte differentiation in vivo but this remains to 
be proven. 
Novel Gene Products of  Fat Cells 
By any morphological or biochemical criteria, the change 
from a fibroblastic preadipocyte to an adipocyte is very dra- 
matic.  Early  electrophoretic  studies  of preadipocyte and 
adipocyte proteins indicated that there were major quantita- 
tive changes in at least 100 protein species (27) and 40% of 
the soluble adipocyte proteins represented newly produced 
material (30). These include many of the important enzymes 
involved in fatty acid and triglyceride synthesis, such as (to 
name only a  few)  glycerophosphate dehydrogenase,  fatty 
acid synthetase, phosphoenolpyruvate carboxykinase, acetyl 
CoA carboxylase, hormone-sensitive lipase, lipoprotein li- 
pase,  and malic enzyme. The electrophoretic studies cited 
above  suggested that  there  are  proteins  produced  during 
adipocyte differentiation in addition to the well known lipid- 
producing enzymes. This was clearly shown by the cloning 
and sequencing of several  abundant, differentiation-depen- 
dent cDNAs. These include a novel homologue of myelin P2 
protein,  which  also  shares  some  NH2-terminal  sequence 
homology with a family of intracellular lipid carrier proteins 
that includes liver fatty acid-binding protein, intestinal heart 
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ing protein (1, 7). The precise function of this putative lipid 
carrier protein, termed adipocyte P2 (aP2) I or 422 protein 
remains  to  be determined.  Another  novel adipocyte gene 
product is  the  serine protease homolog adipsin,  formerly 
called 28K (6). This protein, which has a catalytic "charge- 
relay" system and an activation peptide typical of serine pro- 
teases, is greatly altered quantitatively in certain models of 
obesity (6,  14). A third newly identified gene product of fat 
cells  encodes a  member of the  cytochrome P-450  family 
(Ringold, G., personal communication). There is no reason 
to believe there are not many other important,  adipocyte- 
specific gene products which await description and analysis. 
In light of the suggested roles of adipose tissue in the regula- 
tion of systemic energy balance, further studies may prove 
invaluable. 
Regulation of Adipocyte Gene Expression 
In virtually every case so far examined, new specific protein 
synthesis in the adipocyte is accompanied by increases in the 
related mRNA levels. Transcriptional analysis using isolated 
preadipocyte and adipocyte nuclei have shown that changes 
in transcription play a  major role in altered mRNA abun- 
dance (2, 7, 12). Additionally, discordances between relative 
transcription rates and specific mRNA abundances have sug- 
gested that at least two fat cell mRNAs,  aP2 and adipsin, 
might become especially abundant due to their great stability 
in the fat cell (7,  12). 
The aP2 gene was chosen for further analysis of mecha- 
nisms controlling transcription because this gene is small (4 
kb) and has a relatively simple structure (18). The entire aP2 
gene, containing 2 kb of 5' flanking sequence was stably in- 
troduced into  3T3-F442A  preadipocytes after inserting  a 
linker into a  unique restriction site in the third exon (18). 
This  marked  gene  was  expressed  only  upon  adipocyte 
differentiation and did so with a time course indistinguish- 
able from the endogenous aP2 gene. We then began to exam- 
ine  particular  sequences  within  this  gene  for  regulatory 
properties. The isolation of several genes which are activated 
in  adipocyte differentiation but belong  to  distinct protein 
families allowed a  search for sequence homologies which 
might  represent core elements involved in  differentiation- 
dependent transcription. Two elements were described, which 
we termed "fat-specific elements" (FSEs, reference 18). FSE1 
is a 14-base sequence which is present in multiple nonidenti- 
cal copies in the 5' flanking region of 3 genes: glycerophos- 
phate dehydrogenase, aP2, and adipsin.  FSE2 is present in 
a single copy on the 5' flanking regions of only the glycero- 
phosphate dehydrogenase and aP2 genes, matching at 13 out 
of 14 bases (18, 23). Since the sequence match was very close 
for the FSE2 element, we asked if this represented a protein 
binding site for a nuclear factor. Gel retardation analysis in- 
dicated that  a  sequence-specific protein or proteins inter- 
acted at this site (ll). Furthermore, there was a very dramatic 
shift  in  mobility  during  differentiation;  preadipose  cells 
yielded a very broad streaking pattern while fat cells gave 
rise to a single distinct band. 
There is also a change in apparent function of the FSE2 
associated with the preadipose to adipose conversion. Only 
1. Abbreviations used in this paper: aP2, adipocyte P2;  FSEs, fat-specific 
elements. 
168 bases of 5' flanking sequence of the aP2 gene are re- 
quired to drive differentiation-dependent expression of a het- 
erologous marker gene, bacterial chloramphenicol acetyl- 
transferase (CAT)  in  transient assays (11). When deletions 
from -144 to -120 removed the FSE2 site (located at -124), 
the expression of CAT  was greatly increased in preadipo- 
cytes, whereas adipocyte expression decreased in this dele- 
tion. The FSE2 was also analyzed by cotransfecting a 50-fold 
molar excess of FSE2 duplex DNA (as a 28-mer) with the 
parent paP2-CAT (-168) plasmid. This also had the effect 
of increasing expression in preadipose cells but had no effect 
on fat cell expression. These data strongly suggest that the 
FSE2 functions as a negative regulator in preadipocytes and 
is recognized by a trans-acting factor. There is also a positive 
acting element near the FSE2 in fat cells, but whether it lies 
slightly upstream of FSE2 or includes the FSE2 is still unclear. 
fos Involvement in aP2 Expression 
The identification of a sequence associated with the preadi- 
pose to adipose conversion led to a study of the trans-acting 
complexes bound to the FSE2 site.  Surprisingly, the FSE2 
element turned out to be a target sequence for the binding 
of a protein complex involving the product of the c-fos pro- 
tooncogene or other fos-like proteins (Fos). While binding 
of adipocyte-specific factors resided in a single band in a gel 
retardation assay,  binding of preadipocyte factors appeared 
as a broad streak. The heterogeneity of the preadipocyte pat- 
tern suggested that the FSE2-binding complexes contained 
highly modified proteins. This hypothesis led us to test the 
notion that the nuclear protooncogene c-fos, known to be ex- 
tensively  and  heterogeneously phosphorylated,  might  be 
part of this complex. While a precise sequence target of c-fos 
(or any other nuclear protooncogene) was unknown at this 
time, protein complexes containing this protein were known 
to bind to DNA and were suspected to function as trans- 
acting factors for genes involved in cell growth and differenti- 
ation (9). Using afffinity-purified antibodies prepared against 
a c-fos peptide to disrupt nucleoprotein complexes, it became 
clear that Fos was present in the FSE2-binding material from 
both adipocytes and preadipocytes (11). This disruption of 
factor binding could be completely neutralized by prior ad- 
sorption of antibodies with the cognate c-fos peptide. Anti- 
bodies to other nuclear proteins had no effect on these com- 
plexes. The presence of Fos in the proteins bound to FSE2 
could also  be demonstrated by photo-cross-linking FSE2 
complexes and immunoprecipitating with antibodies directed 
toward different parts of the c-fos molecule (10, 11, 26). A 
role for Fos in the sequence-specific binding was suggested 
by the fact that antibodies to Fos could disrupt preformed 
nucleoprotein complexes. 
More recently, it has been shown that nuclear extracts en- 
riched in either v- or c-fos  show enhanced binding to the 
FSE2 DNA (26). Using a microscale DNA-affinity precipi- 
tation technique followed by two-dimensional electrophore- 
sis,  Franza et al.  (15) have demonstrated directly the pres- 
ence of c-fos protein and a number of Fos-related antigens 
in  protein  complexes that  can bind  to  FSE2  and  closely 
related DNA sequences. 
Suggestions as to the function of Fos in the regulation of 
the aP2 gene have emerged through more detailed definition 
of its binding sequence. Mutation and sequence competition 
studies in vitro have shown that Fos complexes bind DNA 
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identified as the consensus sequence for the binding of mam- 
malian transcription factor AP-1 (22) and yeast transcription 
factor GCN4 (31). AP-1 is a transcription factor which acts 
positively or negatively at a number of enhancers and is be- 
lieved to play a role in enhancers stimulated by the phorbol 
ester tumor promoter, 12-0-tetradecanoyl phorbol-13-acetate 
(22). The simultaneous presence of proteins related to Fos 
and AP-1 in the same fat cell extracts was demonstrated by 
photo-cross-linking of FSE2 complexes and immunoprecip- 
itation with antibodies to c-fos or to a protein closely related 
to AP-I, v-jun (26). AP-1 is closely related or identical to the 
cellular form of this oncogene, c-jun. 
From these results emerged the first suggestion of a func- 
tional relationship between Fos and transcription factor AP-1. 
It is  possible that Fos and AP-I  compete for binding and 
function as transcription factors/transcription inhibitors at 
related sequences. Alternatively, these results are also com- 
patible with these proteins modulating each other's action 
directly, through a protein-protein interaction. Very recent 
evidence suggests that Fos and AP-I may indeed form a sta- 
ble complex which can bind to DNA in a sequence-specific 
manner (25). These data open several very intriguing ques- 
tions. The first is whether Fos itself is a DNA-binding protein 
or is carried into this target sequence by virtue of its putative 
interaction with  AP-1. The evidence that AP-1  is  a  DNA- 
binding protein is quite good; highly purified (though not 
homogeneous) preparations of AP-1 bind DNA in sequence- 
specific fashion (22), as do preparations of v-jun (3), a close 
relative of AP-1. The putative DNA binding domain of v-jun 
will substitute in a functional assay in yeast for a similar do- 
main of the yeast transcription factor GCN4 (31). Although 
Fos protein complexes will bind DNA, there have been no 
reports of purified Fos binding to DNA in a sequence-spe- 
cific manner, suggesting that Fos may well be bound to DNA 
through other proteins such as AP-1. On the other hand, Fos 
bound to FSE2 can be photo-cross-linked to the DNA indi- 
cating a close physical proximity (11). Antibodies to Fos dis- 
rupt native (noncross-linked) nucleoprotein complexes and 
cause the release of free DNA. Our perspective on this data 
is that AP-1 almost certainly is a DNA-binding protein and 
that Fos is very close to the DNA and is likely to influence 
the sequence-specific DNA-binding properties of complexes 
in which it participates. Also unknown is the significance of 
the multiple nuclear proteins which appear to be immuno- 
logically related to Fos and which also bind to the same or 
similar target sequences (15).  Presumably they also play a 
role in the regulation of genes through binding at these target 
sequences. 
Finally, a major question is how the differentiation-depen- 
dent changes in both the structure and function of FSE2 com- 
plexes on the aP2 gene are accomplished. Theoretically, this 
could involve the covalent modification of Fos or other pro- 
teins in this complex, or may represent the addition or sub- 
traction of distinct proteins during the adipocyte differentia- 
tion  process.  Sequence-affinity purification  of the  FSE2 
binding factors from preadipocyte and adipocytes, followed 
by assay using in vitro transcription systems will be required 
to answer this question. Reagents should soon be available 
to analyze Fos function in transcription in great detail. Given 
this precedent in adipocyte development, there is little doubt 
that c-fos, c-jun, and other nuclear protooncogenes partici- 
pate in the regulation of other genes that are important in cell 
growth  and  development.  Identifying  and  analyzing  such 
genes will be an important future step in understanding nor- 
mal and pathological development. 
This review is dedicated  to the memory of our esteemed colleague,  Dr. Eva 
Paucha. 
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